Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alejandro Lazo-Langner

Showing results (31-40 of 135) with videos related to

Pageof 14
Sort By:
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|November 26, 2008
Lessons from ximelagatran: issues for future studies evaluating new oral direct thrombin inhibitors for venous thromboembolism prophylaxis in orthopedic surgeryAlejandro Lazo-Langner, Marc A Rodger, Philip S Wells
Thrombosis Research|August 14, 2020
Long term monitoring of patients with positive lupus anticoagulant and antiphospholipid antibodies. Are all cases persistently positive?Matthew R Kovacs, Alejandro Lazo-Langner, Michael J Kovacs
Therapeutics and Clinical Risk Management|August 19, 2016
Eculizumab in the management of paroxysmal nocturnal hemoglobinuria: patient selection and special considerationsFatimah Al-Ani, Ian Chin-Yee, Alejandro Lazo-Langner
Revista De Investigacion Clinica; Organo Del Hospital De Enfermedades De La Nutricion|May 9, 2002
[Safety and efficacy of total dose intravenous iron infusion in the treatment of iron-deficiency anemia in adult non-pregnant patients]Eduardo Reynoso-Gómez, Victor Salinas-Rojas, Alejandro Lazo-Langner
Thrombosis Research|November 14, 2016
Retinal vein thrombosis: The Internist's role in the etiologic and therapeutic managementAlejandro Garcia-Horton, Fatimah Al-Ani, Alejandro Lazo-Langner
Thrombosis and Haemostasis|January 2, 2020
Development of a Clinical Prediction Rule for Venous Thromboembolism in Patients with Acute LeukemiaFatimah Al-Ani, Yimin Pearl Wang, Alejandro Lazo-Langner
Thrombosis Research|November 7, 2020
Current estimates of the incidence of acute venous thromboembolic disease in Canada: A meta-analysisJames G Payne, Vicky Tagalakis, Cynthia Wu, et al.
Annals of Hepatology|May 3, 2021
COVID-19 vaccine-induced immune thrombotic thrombocytopenia: An emerging cause of splanchnic vein thrombosisMateo Porres-Aguilar, Alejandro Lazo-Langner, Arturo Panduro, et al.
The Canadian Journal of Cardiology|June 12, 2012
Cardiac conduction block at multiple levels caused by arsenic trioxide therapyKala Kathirgamanathan, Paul Angaran, Alejandro Lazo-Langner, et al.
Haematologica|March 23, 2010
Low molecular weight heparin for the treatment of retinal vein occlusion: a systematic review and meta-analysis of randomized trialsAlejandro Lazo-Langner, Jeff Hawel, Walter Ageno, et al.
Pageof 14

Showing results (31-40 of 135) with videos related to

Sort By:
Pageof 14
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|November 26, 2008
Lessons from ximelagatran: issues for future studies evaluating new oral direct thrombin inhibitors for venous thromboembolism prophylaxis in orthopedic surgeryAlejandro Lazo-Langner, Marc A Rodger, Philip S Wells
Thrombosis Research|August 14, 2020
Long term monitoring of patients with positive lupus anticoagulant and antiphospholipid antibodies. Are all cases persistently positive?Matthew R Kovacs, Alejandro Lazo-Langner, Michael J Kovacs
Therapeutics and Clinical Risk Management|August 19, 2016
Eculizumab in the management of paroxysmal nocturnal hemoglobinuria: patient selection and special considerationsFatimah Al-Ani, Ian Chin-Yee, Alejandro Lazo-Langner
Revista De Investigacion Clinica; Organo Del Hospital De Enfermedades De La Nutricion|May 9, 2002
[Safety and efficacy of total dose intravenous iron infusion in the treatment of iron-deficiency anemia in adult non-pregnant patients]Eduardo Reynoso-Gómez, Victor Salinas-Rojas, Alejandro Lazo-Langner
Thrombosis Research|November 14, 2016
Retinal vein thrombosis: The Internist's role in the etiologic and therapeutic managementAlejandro Garcia-Horton, Fatimah Al-Ani, Alejandro Lazo-Langner
Thrombosis and Haemostasis|January 2, 2020
Development of a Clinical Prediction Rule for Venous Thromboembolism in Patients with Acute LeukemiaFatimah Al-Ani, Yimin Pearl Wang, Alejandro Lazo-Langner
Thrombosis Research|November 7, 2020
Current estimates of the incidence of acute venous thromboembolic disease in Canada: A meta-analysisJames G Payne, Vicky Tagalakis, Cynthia Wu, et al.
Annals of Hepatology|May 3, 2021
COVID-19 vaccine-induced immune thrombotic thrombocytopenia: An emerging cause of splanchnic vein thrombosisMateo Porres-Aguilar, Alejandro Lazo-Langner, Arturo Panduro, et al.
The Canadian Journal of Cardiology|June 12, 2012
Cardiac conduction block at multiple levels caused by arsenic trioxide therapyKala Kathirgamanathan, Paul Angaran, Alejandro Lazo-Langner, et al.
Haematologica|March 23, 2010
Low molecular weight heparin for the treatment of retinal vein occlusion: a systematic review and meta-analysis of randomized trialsAlejandro Lazo-Langner, Jeff Hawel, Walter Ageno, et al.
Pageof 14